194 related articles for article (PubMed ID: 18811882)
1. Association between polymorphisms of microsomal epoxide hydrolase and COPD: results from meta-analyses.
Hu G; Shi Z; Hu J; Zou G; Peng G; Ran P
Respirology; 2008 Nov; 13(6):837-50. PubMed ID: 18811882
[TBL] [Abstract][Full Text] [Related]
2. [Study on the relationship between EPHX1 gene polymorphism and antioxidant capacity in patients with chronic obstructive pulmonary disease].
Luo Y; Dai LM; Jia M; Zhao ZH; Hu CM; Qi WY; Zhang JQ
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):760-764. PubMed ID: 31594110
[No Abstract] [Full Text] [Related]
3. Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta-analysis.
Li H; Fu WP; Hong ZH
Oncol Lett; 2013 Mar; 5(3):1022-1030. PubMed ID: 23426996
[TBL] [Abstract][Full Text] [Related]
4. Microsomal epoxide hydrolase gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in the Tunisian population.
Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH
Genet Test Mol Biomarkers; 2010 Dec; 14(6):857-63. PubMed ID: 20932192
[TBL] [Abstract][Full Text] [Related]
5. TNF-308 gene polymorphism is associated with COPD risk among Asians: meta-analysis of data for 6,118 subjects.
Zhan P; Wang J; Wei SZ; Qian Q; Qiu LX; Yu LK; Song Y
Mol Biol Rep; 2011 Jan; 38(1):219-27. PubMed ID: 20364405
[TBL] [Abstract][Full Text] [Related]
6. Effect of N-acetylcysteine in COPD patients with different microsomal epoxide hydrolase genotypes.
Zhang JQ; Zhang JQ; Liu H; Zhao ZH; Fang LZ; Liu L; Fu WP; Shu JK; Feng JG; Dai LM
Int J Chron Obstruct Pulmon Dis; 2015; 10():917-23. PubMed ID: 25999707
[TBL] [Abstract][Full Text] [Related]
7. Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.
Penyige A; Poliska S; Csanky E; Scholtz B; Dezso B; Schmelczer I; Kilty I; Takacs L; Nagy L
BMC Med Genet; 2010 Nov; 11():152. PubMed ID: 21044285
[TBL] [Abstract][Full Text] [Related]
8. Combined analysis of EPHX1, GSTP1, GSTM1 and GSTT1 gene polymorphisms in relation to chronic obstructive pulmonary disease risk and lung function impairment.
Lakhdar R; Denden S; Knani J; Leban N; Daimi H; Hassine M; Lefranc G; Chibani JB; Khelil AH
Dis Markers; 2011; 30(5):253-63. PubMed ID: 21734345
[TBL] [Abstract][Full Text] [Related]
9. EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
Lee J; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Jan; 37(1):18-25. PubMed ID: 20516053
[TBL] [Abstract][Full Text] [Related]
10. Association between microsomal epoxide hydrolase 1 polymorphisms and susceptibility to esophageal cancer: a meta-analysis.
Zhao W; Luo J; Cai X
Tumour Biol; 2013 Aug; 34(4):2383-8. PubMed ID: 23681797
[TBL] [Abstract][Full Text] [Related]
11. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample.
Matheson MC; Raven J; Walters EH; Abramson MJ; Ellis JA
Hum Biol; 2006 Dec; 78(6):705-17. PubMed ID: 17564249
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response.
Chen CZ; Wang RH; Lee CH; Lin CC; Chang HY; Hsiue TR
J Formos Med Assoc; 2011 Nov; 110(11):685-9. PubMed ID: 22118311
[TBL] [Abstract][Full Text] [Related]
13. Association between TNF-α -308 G/A polymorphism and COPD susceptibility: a meta-analysis update.
Zhang L; Gu H; Gu Y; Zeng X
Int J Chron Obstruct Pulmon Dis; 2016; 11():1367-79. PubMed ID: 27382273
[TBL] [Abstract][Full Text] [Related]
14. Systematic review and meta-analysis of the relationship between EPHX1 polymorphisms and colorectal cancer risk.
Liu F; Yuan D; Wei Y; Wang W; Yan L; Wen T; Xu M; Yang J; Li B
PLoS One; 2012; 7(8):e43821. PubMed ID: 22928041
[TBL] [Abstract][Full Text] [Related]
15. Exploration of association between EPHX1 and chronic obstructive pulmonary disease on the basis of combined data mining.
An L; Xia H; Zhou P; Hua L
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173271
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-β1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis.
Zhang L; Chang WW; Ding H; Su H; Wang HY
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1301-7. PubMed ID: 21740629
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD.
Cheng SL; Yu CJ; Chen CJ; Yang PC
Eur Respir J; 2004 Jun; 23(6):818-24. PubMed ID: 15218992
[TBL] [Abstract][Full Text] [Related]
18. [Microsomal epoxide hydrolase gene polymorphism and susceptibility to chronic obstructive pulmonary disease in Han nationality of North China].
Zhang R; Zhang A; He Q; Lu B
Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):11-4. PubMed ID: 11940289
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population.
Zidzik J; Slabá E; Joppa P; Kluchová Z; Dorková Z; Skyba P; Habalová V; Salagovic J; Tkácová R
Croat Med J; 2008 Apr; 49(2):182-91. PubMed ID: 18461673
[TBL] [Abstract][Full Text] [Related]
20. EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.
Dura P; Bregitha CV; Te Morsche RH; Roelofs HM; Kristinsson JO; Wobbes T; Witteman BJ; Tan AC; Drenth JP; Peters WH
Oncol Rep; 2012 Jun; 27(6):1710-6. PubMed ID: 22447130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
